The directory is taking shape. Reviewed clinic profiles are coming soon.
Regenerative
Clinic Guide
Regulation

Off-label use

Also known as: unapproved use of an approved drug

Use of an approved product in a way outside its approved labeling; FDA’s patient guide explains this in the context of approved drugs.

Source-checked educational compilation · Not independently clinically reviewed

What this means in a clinic conversation

A different condition, dose or route may be involved. An unidentified or unapproved product should not automatically be called off-label; first establish which approved product is being discussed.

A question to bring

What is the approved product, and how does the proposed use differ from its labeling?

Open the visit checklist →

Related and commonly confused terms

Use the term in context

Sources and editorial context

This definition was compiled from the sources below and has not received independent clinical review. It supports understanding and consultation preparation.

  1. Understanding Unapproved Use of Approved Drugs: Off Label · U.S. Food and Drug AdministrationReference checked 2026-10-02
Back to the A–Z glossary →